Torrent–JB Pharma deal gets India nod after monopoly fears
India’s antitrust regulator conditionally approved Torrent’s acquisition of JB Chemicals in October 2025, citing near-monopolies in certain probiotic and Nifedipine markets, but cleared the deal after voluntary remedies to address competition...To view the full article, register now.
Already a subscriber? Click here to view full article